InvestorsHub Logo
Post# of 252339
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: dav1234 post# 164817

Tuesday, 08/27/2013 7:35:12 AM

Tuesday, August 27, 2013 7:35:12 AM

Post# of 252339
OncoGenex initiates panreatic cancer trial
OncoGenex (OGXI) initiates a Phase 2 study of an apatorsen/ Abraxane/ gemcitabine combo in patients with previously untreated metastatic pancreatic cancer.Primary endpoint is overall survival.Also evaluated: Progression-free survival, tumor response rates, safety, tolerability, and the effect of therapy on heat shock protein 27 levels

http://seekingalpha.com/news-article/7427902-oncogenex-announces-that-the-rainier-clinical-trial-evaluating-apatorsen-ogx-427-in-combination-with-abraxane-plus-gemcitabine-in-patients-with-metastatic-pancreatic-cancer-is-now-open-for-enrollment

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.